Presented by Delphine Vauterin (University, Ghent, Belgium)
Smoking remains to be a major modifiable risk factor in asthma and COPD. However, despite the well-established health risks, many patients continue to smoke. Both patients and physicians face barriers when discussing smoking cessations. In fact, patients often struggle with nicotine dependence, while physicians often have limited time, awareness, or confidence in addressing cessation. At ERS 2025, Delphine Vauterin, PhD student at the Ghent University, presented the results of a study aimed at the identification of clinical events that may increase patient receptiveness to smoking cessation (teachable moments) and assess their association with cessation attempts.
Using a nationwide cohort of individuals prescribed at least two medications for airway diseases, they examined the occurrence of key clinical events and their relationship with smoking cessation attempts. Events known from prior literature, such as acute myocardial infarction or critical care admission, were confirmed as strong predictors of cessation attempts. Importantly, the study also revealed that spirometry testing and exacerbations, particularly if they lead to hospitalization, significantly increase the likelihood of smoking cessation attempts.
These findings emphasize the importance of capitalizing on clinical encounters, especially during exacerbations and lung function testing, to encourage patients with an obstructive airway disease towards smoking cessation.
References:
Vauterin D, et al. ERS2025; Abstract 3760.